Literature DB >> 11373169

Actions of gonadotrophins on the uterus.

M Shemesh1.   

Abstract

Binding sites for LH/hCG are found in the uterus of several species, including humans. In cattle and pigs, the LH receptor, its mRNA and LH receptor protein are present in the uterus throughout the oestrous cycle, and maximum expression occurs at the luteal phase. GnRH receptor is also expressed maximally in the human endometrium at the luteal phase. LH activates both the adenylate cyclase and phospholipase C pathways and increases the concentrations of cyclooxygenase and its products. Activation of LH receptors in the endometrium is associated with PGF production. In contrast, bovine uterine vein LH receptor mRNA and LH receptor concentrations are greatest during pro-oestrus-oestrus and LH increases the production of both PGE and PGF. FSH receptor and its mRNA are present in the bovine cervix and the concentrations are greatest at the time of the FSH peak value in the blood, indicating a physiological role for FSH in the relaxation and opening of the cervix. The presence of gonadotrophin and releasing factor receptors with a dynamic pattern in the endometrium, myometrium, oviduct and cervix of different species provides evidence that gonadotrophins and GnRH play a substantial role as molecular autocrine-paracrine regulators of the oestrous cycle and implantation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373169     DOI: 10.1530/rep.0.1210835

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  21 in total

1.  Gonadotropin-induced changes in oviducal mRNA expression levels of sex steroid hormone receptors and activin-related signaling factors in the alligator.

Authors:  Brandon C Moore; Sara Forouhar; Satomi Kohno; Nicole L Botteri; Heather J Hamlin; Louis J Guillette
Journal:  Gen Comp Endocrinol       Date:  2011-12-01       Impact factor: 2.822

2.  Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: a meta-analysis.

Authors:  João Batista A Oliveira; Ana Lucia Mauri; Claudia G Petersen; Anice M C Martins; João Cornicelli; Mario Cavanha; Anagloria Pontes; Ricardo L R Baruffi; José G Franco
Journal:  J Assist Reprod Genet       Date:  2006-12-29       Impact factor: 3.412

3.  GnRH antagonists may affect endometrial receptivity.

Authors:  Beth W Rackow; Harvey J Kliman; Hugh S Taylor
Journal:  Fertil Steril       Date:  2008-04-14       Impact factor: 7.329

4.  A novel compound heterozygous mutation of the luteinizing hormone receptor -implications for fertility.

Authors:  Frederic Mitri; Yaakov Bentov; Lucy Ann Behan; Navid Esfandiari; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2014-05-22       Impact factor: 3.412

5.  Polycystic ovary syndrome and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Julie R Palmer; Elizabeth A Stewart; Lynn Rosenberg
Journal:  Fertil Steril       Date:  2007-01-22       Impact factor: 7.329

6.  Fertility in luteinizing hormone receptor-knockout mice after wild-type ovary transplantation demonstrates redundancy of extragonadal luteinizing hormone action.

Authors:  Tomi Pakarainen; Fu-Ping Zhang; Matti Poutanen; Ilpo Huhtaniemi
Journal:  J Clin Invest       Date:  2005-06-09       Impact factor: 14.808

7.  Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.

Authors:  Jin Yeong Kim; Haengseok Song; Hyunjoo Kim; Hee Jung Kang; Jin Hyun Jun; Sung Ran Hong; Mi Kyoung Koong; In Sun Kim
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

8.  The LH/hCG Axis in Endometrial Cancer: A New Target in the Treatment of Recurrent or Metastatic Disease.

Authors:  A Arcangeli; I Noci; A Fortunato; G F Scarselli
Journal:  Obstet Gynecol Int       Date:  2010-07-15

Review 9.  Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.

Authors:  João Batista A Oliveira; Ricardo Baruffi; Cláudia G Petersen; Ana L Mauri; Mario Cavagna; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2010-09-08       Impact factor: 5.211

10.  Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study.

Authors:  José G Franco; Ricardo L R Baruffi; João Batista A Oliveira; Ana L Mauri; Claudia G Petersen; Paula Contart; Valeria Felipe
Journal:  Reprod Biol Endocrinol       Date:  2009-06-04       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.